Liver International
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 1
-
Bridging all oral DAA therapy from wait time to post‐liver transplant to improve HCV eradication?Donato, Maria Francesca / Monico, Sara / Malinverno, Federica et al. | 2015
- 5
-
PRO view: treat to prevent recurrence of HCVEverson, Gregory T. et al. | 2015
- 7
-
Sofosbuvir and ribavirin use in wait‐listed patients with hepatitis C should be selectivePrice, Jennifer C. / Terrault, Norah A. et al. | 2015
- 9
-
Treatment of HCV prior to liver transplantation to prevent HCV recurrence – Wise or wasteful?Gallegos‐Orozco, Juan F. / Charlton, Michael R. et al. | 2015
- 12
-
Appraising cardiac dysfunction in liver transplantation: an ongoing challengeZaky, Ahmed / Bendjelid, Karim et al. | 2015
- 30
-
Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta‐analysisAkhtar, Ehsaan / Manne, Vignan / Saab, Sammy et al. | 2015
- 37
-
Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosisReuken, Philipp A. / Kussmann, Anna / Kiehntopf, Michael et al. | 2015
- 46
-
CLIF‐SOFA scoring system accurately predicts short‐term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysisLee, Minjong / Lee, Jeong‐Hoon / Oh, Sohee et al. | 2015
- 58
-
Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD‐EEGMontagnese, Sara / De Rui, Michele / Schiff, Sami et al. | 2015
- 65
-
Burden of HIV and hepatitis C co‐infection: the changing epidemiology of hepatitis C in HIV‐infected patients in FranceCacoub, Patrice / Dabis, François / Costagliola, Dominique et al. | 2015
- 71
-
eGFR decrease during antiviral C therapy with first generation protease inhibitors: a clinical significance?Loustaud‐Ratti, Véronique / Rousseau, Annick / Carrier, Paul et al. | 2015
- 79
-
Mericitabine and ritonavir‐boosted danoprevir with or without ribavirin in treatment‐naive HCV genotype 1 patients: INFORM‐SVR studyGane, Edward J. / Pockros, Paul J. / Zeuzem, Stefan et al. | 2015
- 90
-
Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysisCalleja, Jose L. / Pascasio, Juan M. / Ruiz‐Antorán, Belén et al. | 2015
- 101
-
Liver inflammation is a risk factor for prediabetes in at‐risk latinos with and without hepatitis C infectionBurman, Blaire E. / Bacchetti, Peter / Ayala, Claudia E. et al. | 2015
- 108
-
DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha‐2a/ribavirin in HCV genotypes 1 or 4Everson, Gregory / Cooper, Curtis / Hézode, Christophe et al. | 2015
- 120
-
OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon‐naïve patients with HIV/HCV genotype 2/3 co‐infection in ItalyBruno, Raffaele / Cariti, Giuseppe / Nasta, Paola et al. | 2015
- 130
-
Loss of hepatitis B surface antigen in a real‐life clinical cohort of patients with chronic hepatitis B virus infectionHabersetzer, François / Moenne‐Loccoz, Rémy / Meyer, Nicolas et al. | 2015
- 140
-
Long‐term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearanceLauret, Eugenia / González‐Diéguez, María L. / Rodríguez, Mercedes et al. | 2015
- 148
-
Prevalence of renal abnormalities in chronic HBV infection: The HARPE studyAmet, Sabine / Bronowicki, Jean‐Pierre / Thabut, Dominique et al. | 2015
- 156
-
Donor information based prediction of early allograft dysfunction and outcome in liver transplantationHoyer, Dieter P. / Paul, Andreas / Gallinat, Anja et al. | 2015
- 164
-
The impact of obesity on patient survival in liver transplant recipients: a meta‐analysisSaab, Sammy / Lalezari, David / Pruthi, Paridhima et al. | 2015
- 171
-
Alcohol abuse in deceased liver donors: impact on post‐transplant outcomesMangus, Richard S / Kubal, Chandrashekhar A / Fridell, Jonathan A et al. | 2015
- 176
-
Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantationFarnik, Harald / Zimmermann, Tim / Herrmann, Eva et al. | 2015
- 184
-
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18Biselli, Maurizio / Dall'Agata, Marco / Gramenzi, Annagiulia et al. | 2015
- 192
-
Boceprevir in liver transplant recipientsSaab, Sammy / Manne, Vignan / Bau, Sherona et al. | 2015
- 198
-
Alpha‐1‐antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in humanGiovannoni, Isabella / Callea, Francesco / Stefanelli, Marta et al. | 2015
- 207
-
Metabolomic tissue signature in human non‐alcoholic fatty liver disease identifies protective candidate metabolitesvon Schönfels, Witigo / Patsenker, Eleonora / Fahrner, René et al. | 2015
- 215
-
Gene variants encoding proteins involved in antioxidant defense system and the clinical expression of Wilson diseaseGromadzka, Grażyna / Kruszyńska, Monika / Wierzbicka, Diana et al. | 2015
- 223
-
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20‐year survey by the Italian Liver Cancer groupFarinati, Fabio / Vanin, Veronica / Giacomin, Anna et al. | 2015
- 232
-
Reappraisal of serum alpha‐foetoprotein as a surveillance test for hepatocellular carcinoma during entecavir treatmentKim, Gi‐Ae / Seock, Chang Hyeon / Park, Jang Won et al. | 2015
- 240
-
miR‐181a mediates TGF‐β‐induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancerBrockhausen, Jennifer / Tay, Szun S. / Grzelak, Candice A. et al. | 2015
- 254
-
Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatographyvon Seth, Erik / Arnelo, Urban / Enochsson, Lars et al. | 2015
- 263
-
Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitisBell, Lauren N / Wulff, Jacob / Comerford, Megan et al. | 2015
- 275
-
Low‐dose anti‐CD3 antibody induces remission of active autoimmune hepatitis in xenoimmunized miceMarceau, Gabriel / Yang, Roland / Lapierre, Pascal et al. | 2015
- 285
-
Interfering parameters in nonalcoholic fatty liver disease fibrosis scoreSertoglu, Erdim / Kayadibi, Huseyin / Uyanik, Metin et al. | 2015
- 285
-
Response to Dr. Sertoglu and ColleaguesPetta, Salvatore / Vanni, Ester / Craxì, Antonio et al. | 2015
- 286
-
Laboratory assessment may be dependent on the time of liver biopsyKayadibi, Huseyin / Sertoglu, Erdim / Uyanik, Metin et al. | 2015
- 287
-
Response to: Laboratory assessment may be dependent on the time of liver biopsyGoh, George B / Pagadala, Mangesh / Dasarathy, Jaividhya et al. | 2015
- i
-
Issue Information| 2015